MULTI DOSE MD
- Manufacturer
- DeLaval Inc | West Agro, Inc. | Hill's Supply, Inc | Great Lakes Dairy Supply, Inc | Dairymen Specialty Co., Inc | JBZ Dairy Advantage Inc | Ederer Dairy Supply LLC | DeLaval Inc. | Meyer Electric and Farm, Inc
- Effective date
- 2026-11-06
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 16
- Source
- daily-update
- Hydrated at
- 2026-11-12 02:01:17
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
DeLaval Multi Dose MD™
Concentrated Disinfecting Teat Dip
Aids in reducing the spread of mastitis-causing organisms
Sellador Concentrado Para Pezones
Ayuda a reducir la transmission de microoganismsos que causan mastis
ACTIVE INGREDIENTS
Iodine........................................4.0% W/V
OTHER INGREDIENTS
Emollient* ..................... 40.0% W/V
*From glycerin and propylene glycol
AFTER DILUTION ACCORDING TO INSTRUCTIONS:
Iodine..........1.0% Emollient..........10.0%
Iodine..........0.75% Emollient.......... 7.5%
Iodine..........0.5% Emollient.......... 5.0%
Iodine..........0.25% Emollient.......... 2.5%
Iodine..........0.1% Emollient.............1.0%
KEEP OUT OF REACH OF CHILDREN
! CAUTION
MANTENER FUERA DEL ALCANCE DE LOS NINOS
! CUIDADO
1323
NDC NUMBER: 55756-323
SI USTED NO PUEDE LEER ESTA ETIQUETA, POR FAVOR PIDA A ALGUIEN MAS QUE SE LA LEA ANTES DE USAR ESTE PRODUCTO
READ AND UNDERSTAND ALL INSTRUCTIONS BEFORE USING THIS PRODUCT
FIRST AID
Contact with product can cause irritation to eyes. Avoid contact with eyes.
If in Eyes: Flush with water. Remove contact lenses, if present, after first 5 minutes. Then continue rinsing. Get immediate medical attention.
If Swallowed: Do not induce vomiting. If victim is fully conscious, give a cupful of water. Never give anything my mouth to an unconscious person. Get immediate medical attention.
STORAGE AND DISPOSAL
THOROUGHLY RINSE ALL MEASURING DEVICES AND STORE OUT OF REACH OF CHILDREN. Avoid contact with food or feed. Avoid storing near heat or open flame. Keep container tightly closed when not in use. If product has frozen, thaw in a warm room and shake well before use. Do not reuse empty container. Rinse empty container before disposing of in a safe manner. Do not store in direct sunlight. Store this product in an area where temperatures are less than 95°F.
CHEM-TREC EMERGENCY NUMBER 1-800-424-9300
Not for Human Use
Additional Information on Safety Data Sheet
Instructions for Use
Follow dilution directions below to achieve the desired formula. DeLaval recommends blending with DeLaval's automatic and manual dispensing systems.
Failure to follow these mixing instructions could cause injury to your animals or reduce the effectiveness of the product as a teat dip.
1.0%-10%PostDip | 0.75%-7.5%PostDip | 0.5%-5%Pre-PostDip | 0.25%-2.5%PreDip | 0.1%-1%PreDip |
1 gallon Multi Dose MD ™ to 3 gallons of water | 1 gallon Multi Dose MD ™ to 4.3 gallons of water | 1 gallon Multi Dose MD ™ to 7 gallons of water | 1 gallon Multi Dose MD ™ to 15 gallons of water | 1 gallon Multi Dose MD ™ to 39 gallons of water |
Use within 6 months | Use within 6 months | Use within 6 months | Use within 2 weeks | Use within 24 hours |
Use Directions
- Do not use concentrate at full strength. Must dilute per instructions above.
- Consult your veterinarian before starting or continuing to use teat dip if cow's teats are sore or chapped.
- Discard any teat dipping solution that becomes dirty or contaminated.
- Clean and sanitize teats before milking to avoid contamination and assist in control of mastitis.
- Post Milking: Dip teats to assist in control of mastitis.
Pre-Dipping
- Remove excess organic debris and forestrip.
- Dip or spray cow's teats with properly diluted DeLaval Multi Dose MD™.
- Allow a 30 second contact time.
- Dry teats thoroughly with a clean, single-service paper towel.
- Attach milker unit.
Post-Dipping
- Immediately after removing the milker unit, dip or spray each teat with properly diluted DeLaval Multi Dose MD™.
- Before exposing cows to below-freezing temperatures, the teats should be thoroughly dry to reduce the potential of frostbite. Failure to follow these instructions may result in frozen teats and injured animals.
Undiluted product may undergo an increase in viscosity when exposed to cold temperatures. Pumps must be recalibrated in those conditions to maintain accurate dosing. If product freezes, thaw it completely and mix properly before use. Consult your DeLaval representative for questions in specific applications.
NET CONTENTS: US GAL. ( L)
LOT NO.:
EXP. DATE:
Manufactured for: DeLaval Inc.
11100 N. Congress Avenue
Kansas City, MO 64153
Phone: 816-891-7700
Manufactured by: West Agro, Inc.
©2024, Made in USA
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5f30b278-5791-4113-8781-878a9221ef8a | Product name | 2 | 20230125 |
| 2a70c781-a755-4d76-b20a-a958acfbdcdc | Product name | 2 | 20190619 |
| 304592ef-4a8a-4c22-8e8c-af73aa3d60e5 | Product name | 1 | 20180703 |
| ac0821a1-ce75-4ea7-880a-59eecaecdf22 | Product name | 1 | 20180703 |
| db5dc4f9-b907-46f6-8fb7-babcf04bbe5c | Product name | 1 | 20180619 |
| 41e9d6cf-3ed7-4c44-a57e-0685058d0896 | Product name | 1 | 20170824 |
| 5e652c92-68fd-426b-b0e7-5fc64e0b9f99 | Product name | 1 | 20170309 |
| ddc0c11a-bba8-408f-b3c7-c4828b4bcc8c | Product name | 1 | 20150421 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IODINE | ACTIVE INGREDIENT | 9679TC07X4 | 2 | |
| IODINE | ACTIVE MOIETY | 9679TC07X4 | 2 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 2 | |
| C9-11 PARETH-8 | INACTIVE INGREDIENT | 80E6PSE1XL | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| POLOXAMER 335 | INACTIVE INGREDIENT | G6DQL26D50 | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 2 | |
| SODIUM IODIDE | INACTIVE INGREDIENT | F5WR8N145C | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- Multi Dose MD
- Iodine
- glycerin
- C9-11 PARETH-8
- POLOXAMER 335
- PROPYLENE GLYCOL
- SODIUM IODIDE
- ANHYDROUS CITRIC ACID
- SODIUM HYDROXIDE
- water
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55756-323 | 55756-323-01, 55756-323-27, 55756-323-02, 55756-323-23 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| IODINE | 9679TC07X4 | ACTIB |
| glycerin | PDC6A3C0OX | IACT |
| C9-11 PARETH-8 | 80E6PSE1XL | IACT |
| POLOXAMER 335 | G6DQL26D50 | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SODIUM IODIDE | F5WR8N145C | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| water | 059QF0KO0R | IACT |
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 15 | 2025-03-02 | full-release | 2026-06-01 02:44:23 |
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / ORAL | 7 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | 1 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / PERIODONTAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, EXTENDED RELEASE / TRANSDERMAL | 0.85 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAMUSCULAR | 101 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / SUBCUTANEOUS | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / RESPIRATORY (INHALATION) | 5 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVENOUS | 78 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / TOPICAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LOTION, AUGMENTED / TOPICAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION, CONCENTRATE / INTRAVENOUS | ADJ PH | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | 5700 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | 90400 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | DROPS / OPHTHALMIC | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | 7459 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / OPHTHALMIC | 6 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GRANULE, FOR SUSPENSION / ORAL | 30 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / OPHTHALMIC | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBCONJUNCTIVAL | ADJ PH | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SPRAY, METERED / NASAL | ADJ PH | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | 4000 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRASYNOVIAL | ADJ PH | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRATHECAL | 176 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY, METERED / NASAL | 1.2 mg/1ml | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | 117 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, SOLUBLE / ORAL | 11 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / INTRAVENOUS | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / IONTOPHORESIS | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRACAUDAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAOCULAR | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CONCENTRATE / ORAL | 10 mg/5ml | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVENOUS | 456 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RESPIRATORY (INHALATION) | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, FILM COATED / ORAL | 8 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTERSTITIAL | ADJ PH | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / NASAL | 5 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT, AUGMENTED / TOPICAL | 0.11 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / EPIDURAL | ADJ PH |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
